Focused pharmacogenetics for mental-health medications.
The Psychiatric Report is for people whose main interest is mental-health prescribing: antidepressants for depression or anxiety, antipsychotics, and stimulants for ADHD. Pharmacogenetics is especially well established here, because genes such as CYP2D6 and CYP2C19 strongly influence how many of these medications are metabolized, and both CPIC and the FDA publish specific guidance for them.[1] If your questions are limited to psychiatric medications, this focused report covers that ground at a lower price than the Full Report.
The Psychiatric Report covers the psychiatric drug classes listed below: SSRI, SNRI, and tricyclic antidepressants, antipsychotics, and psychostimulants. For each medication it combines the relevant FDA, CPIC, and DPWG guidance. These are exactly the same psychiatric results you would find inside the Full Report, presented on their own.
This report is deliberately narrow. It does not cover medications outside psychiatry, including pain management, cardiac and blood-thinning drugs, cholesterol medications, chemotherapies, proton pump inhibitors, and every other class shown in the excluded list below. If you take medications in any of those areas, or expect to, the Full Report is the better fit and existing customers can upgrade to it. Like every Gene2Rx report it is informational, is bounded to genes and drugs with published guidance, and inherits the structural-variant limits of consumer array data, such as CYP2D6 gene deletions and duplications that arrays cannot call reliably.
Drug classes this report does not cover (available in the Full Report):
Each drug is grouped by its key gene, and your result is shown as a metabolizer phenotype, for example a CYP2D6 poor metabolizer, together with the recommendation from each source and an evidence strength of Strong, Moderate, or Optional. Because so many psychiatric drugs share the CYP2D6 and CYP2C19 pathways, a single phenotype often affects several medications at once. Gene2Rx accepts genotype data on either the GRCh37 or GRCh38 genome build. Use the report to inform a discussion with your prescriber rather than to change any medication yourself.
$35 from a single genetic data upload. Whole Genome Sequencing VCFs add $15 per report.
Buy Now See example reportInformational only, not medical advice. Gene2Rx uses genotype data you upload and reports only on genes and drugs with published pharmacogenetic guidance. Consumer arrays cannot reliably call some structural variants, such as CYP2D6 gene deletions and duplications. Never start, stop, or change a medication without talking to your prescribing clinician.